Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,219 public trials 2,045 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Innere Medizin II, LKH Feldkirch Feldkirch, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
View Trial Details
Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

NCT04322539

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC-HOPE Tucson, Arizona, United States
  • California Research Institute (CRI) Los Angeles, California, United States
  • City of Hope Comprehensive Cancer Center Los Angeles, California, United States
View all 153 locations
View Trial Details
Completed

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

NCT04330664

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Local Institution - 002-805 Los Angeles, California, United States
  • Local Institution - 002-803 Orange, California, United States
  • Local Institution - 002-828 Chicago, Illinois, United States
  • Local Institution - 002-942 Wichita, Kansas, United States
View all 17 locations
View Trial Details

Related conditions